J1405 Insurance Policy Changes

Antiemetics for Oncology

UnitedHealthcare Community Plan (Medicaid) revised its antiemetic drug policy effective November 1, 2026, adding new risk factors for chemotherapy-induced nausea/vomiting coverage (including 'less than 7 hours of sleep the night before chemotherapy') and replacing 'high anxiety' with 'anxiety/high pretreatment expectation of nausea.' The policy now clarifies that oral antiemetics covered under this policy apply only when administered prior to chemotherapy infusion, not for patient self-administration. Billing teams must update coverage criteria and documentation requirements for all listed antiemetic drugs.